DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on December 17, 2004; DOI: 10.1124/dmd.104.001669


0090-9556/05/3303-388-394$20.00
DMD 33:388-394, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.104.001669v1
33/3/388    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Annaert, P. P.
Right arrow Articles by Brouwer, K. L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Annaert, P. P.
Right arrow Articles by Brouwer, K. L. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DIGOXIN
*PROGESTERONE
*QUERCETIN
*QUINIDINE
*QUINIDINE SULFATE
*VERAPAMIL HYDROCHLORIDE

ASSESSMENT OF DRUG INTERACTIONS IN HEPATOBILIARY TRANSPORT USING RHODAMINE 123 IN SANDWICH-CULTURED RAT HEPATOCYTES

Pieter P. Annaert1, and Kim L. R. Brouwer

Division of Pharmacotherapy and Experimental Therapeutics, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

The purpose of the present study was to explore the utility of sandwich-cultured rat hepatocytes as an in vitro tool to examine drug interactions at the hepatic transport level. Rhodamine 123 was used as a model substrate for P-glycoprotein-mediated biliary excretion. Effects of various types of P-glycoprotein modulation on the biliary excretion index (BEI; a relative measure of the extent of biliary excretion) and the in vitro biliary clearance (CLbile) were determined. Significant reductions in rhodamine 123 BEI and CLbile were noted in the presence of the P-glycoprotein inhibitors verapamil (30–100 µM) and progesterone (100 µM). The P-glycoprotein activator quercetin (10–100 µM) enhanced rhodamine 123 CLbile by approximately 4-fold, with only a minor effect on BEI, suggesting that quercetin had a more pronounced effect on uptake at the basolateral membrane rather than excretion across the canalicular membrane. Treatment of hepatocytes for 48 h with dexamethasone (10 µM) resulted in significant enhancement of CLbile, whereas rifampin (5–50 µM) increased both BEI and CLbile, indicating that the inducing effects of dexamethasone and rifampin were occurring at the basolateral and canalicular membranes, respectively. Total rhodamine 123 uptake in sandwich-cultured rat hepatocytes was partly saturable and was affected by the presence of typical Oatp1a4 substrates (digoxin, quinine, d-verapamil, 17ß-estradiol-D-17ß-glucuronide). In summary, sandwich-cultured rat hepatocytes are a useful tool to study mechanisms of hepatobiliary drug disposition and to predict the potential for drug interactions in hepatic transport.


Address correspondence to: Dr. Kim L. R. Brouwer, Division of Pharmacotherapy and Experimental Therapeutics, School of Pharmacy, CB# 7360 Kerr Hall, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7360. E-mail: kbrouwer{at}unc.edu




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
K. K. Wolf, K. R. Brouwer, G. M. Pollack, and K. L. R. Brouwer
Effect of Albumin on the Biliary Clearance of Compounds in Sandwich-Cultured Rat Hepatocytes
Drug Metab. Dispos., October 1, 2008; 36(10): 2086 - 2092.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. M. Leslie, P. B. Watkins, R. B. Kim, and K. L. R. Brouwer
Differential Inhibition of Rat and Human Na+-Dependent Taurocholate Cotransporting Polypeptide (NTCP/SLC10A1)by Bosentan: A Mechanism for Species Differences in Hepatotoxicity
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1170 - 1178.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. Jigorel, M. Le Vee, C. Boursier-Neyret, M. Bertrand, and O. Fardel
FUNCTIONAL EXPRESSION OF SINUSOIDAL DRUG TRANSPORTERS IN PRIMARY HUMAN AND RAT HEPATOCYTES
Drug Metab. Dispos., October 1, 2005; 33(10): 1418 - 1422.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.